Preterm birth continues to be a major public health challenge in the United States despite our efforts to reduce it. These clinical education videos address the preterm birth issue while tackling important questions and clinical scenarios. For more information on ACOG District II’s preterm birth education, please contact Kristin Zielinski, Medical Education Director, at 518-436-3461 or email@example.com.
Tailored specifically for the generalist obstetrician-gynecologist, this video offers education on the definition and background of preterm birth, the latest clinical trials and evidence-based research supporting the use of 17OHPC, guidance on its appropriate clinical use, and detailed information on establishing an in-office protocol for administration.
This clinical education video is the second in the Preventing Preterm Birth series and has been made possible through educational grant funding from Ther-Rx Corporation. The scientific content within this presentation was developed independently by the ACOG District II 17OHPC Task Force. ACOG District II would like to thank its 17OHPC Task Force, chaired by Peter S. Bernstein, MD, MPH, FACOG, for their time and expertise spent producing this clinical content.
Policy and Access Update on Makena – September 2013
New science has shed light on the predictive nature of the cervix in assessing who may be at risk for preterm birth. Through cervical length screening in at risk populations, it is possible that the detection of a short cervix via transvaginal ultrasound may assist ob-gyns in assessing which patients are truly vulnerable and what steps need to be taken in order to prevent a preterm delivery.
This clinical education video is the first in the Preventing Preterm Birth series and has been made possible through educational grant funding from Watson Pharmaceuticals. ACOG District II would like to thank its Short Cervix Task Force, chaired by Robert Romero, MD, D.Med.Sci., FACOG, for their time and expertise spent producing this clinical content.